| Announce Date | 10/31/2025 |
| EPS Normalized Actual | $0.3 (Beat by $0.0365) |
| EPS GAAP Actual | $0.3 (Beat by $0.0365) |
| Revenue Actual | $3.33411B |
| Revenue Surprise | Beat by $3334.11M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.169 |
| EPS GAAP Estimate | $0.169 |
| Revenue Estimate | $2.948276207B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.7 | 23.34 | 1.66296 | 1.77443 | 1 |
| Dec 2028 | 1.49 | 26.63 | 1.44461 | 1.53608 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0098 | -0.22943 | 3.33411B | 12.82% | 355.51M |
| FQ2 2025 (Jun 2025) | 0.05 | -0.11989 | 3.1477B | 100% | 182.68M |
| FQ1 2025 (Mar 2025) | 0.05 | -0.08732 | 2.87813B | 100% | 72.24M |
| FQ4 2024 (Dec 2024) | 0.0799 | -0.10511 | 3.0528B | 100% | 261.82M |
| FQ3 2024 (Sep 2024) | -0.0415 | -0.18989 | 2.90682B | 100% | 199.07M |
| FQ1 2021 (Mar 2021) | 0 | 0 | 1.51445B | 100% | 1514.45M |
| FQ2 2021 (Jun 2021) | 0 | 0 | 1.64598B | 100% | 1645.98M |
| FQ3 2021 (Sep 2021) | 0 | 0 | 1.73616B | 100% | 1736.16M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.169
Consensus Revenue Estimates
2.948276207B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.4251 | -- | 0.41615 | 0.43469 | 4 |
| FQ3 2027 (Sep 2027) | 0.19112 | -- | 0.18484 | 0.20708 | 2 |
| FQ2 2027 (Jun 2027) | 0.16353 | -- | 0.15816 | 0.17719 | 2 |
| FQ1 2027 (Mar 2027) | 0.17484 | -- | 0.1691 | 0.18944 | 2 |
| FQ4 2026 (Dec 2026) | 0.23811 | -- | 0.23374 | 0.24361 | 2 |
| FQ3 2026 (Sep 2026) | 0.22845 | 104.29 | 0.22426 | 0.23373 | 2 |
| FQ2 2026 (Jun 2026) | 0.17457 | 71.36 | 0.17137 | 0.1786 | 3 |
| FQ1 2026 (Mar 2026) | 0.169 | 70.41 | 0.1659 | 0.1729 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.28B | -- | 4.21B | 4.35B | 6 |
| FQ3 2027 (Sep 2027) | 3.6B | -- | 3.51B | 3.83B | 3 |
| FQ2 2027 (Jun 2027) | 3.47B | -- | 3.39B | 3.7B | 3 |
| FQ1 2027 (Mar 2027) | 3.46B | -- | 3.38B | 3.69B | 3 |
| FQ4 2026 (Dec 2026) | 3.22B | -- | 3.18B | 3.28B | 3 |
| FQ3 2026 (Sep 2026) | 3.15B | -5.83 | 3.11B | 3.21B | 3 |
| FQ2 2026 (Jun 2026) | 3.08B | -2.27 | 3.03B | 3.13B | 3 |
| FQ1 2026 (Mar 2026) | 2.95B | 2.38 | 2.91B | 3B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
5
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.21963 | -0.0098 | -0.22943 | 2341.12% |
| FQ2 2025 (Jun 2025) | 0.16989 | 0.05 | -0.11989 | -239.78% |
| FQ1 2025 (Mar 2025) | 0.13732 | 0.05 | -0.08732 | -174.64% |
| FQ4 2024 (Dec 2024) | 0.18501 | 0.0799 | -0.10511 | -131.55% |
| FQ3 2024 (Sep 2024) | 0.14839 | -0.0415 | -0.18989 | 457.57% |
| FQ1 2021 (Mar 2021) | 0 | 0 | NAN% | |
| FQ2 2021 (Jun 2021) | 0 | 0 | NAN% | |
| FQ3 2021 (Sep 2021) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.98B | $3.33B | $355.51M | 10.66% |
| FQ2 2025 (Jun 2025) | $2.97B | $3.15B | $182.68M | 5.8% |
| FQ1 2025 (Mar 2025) | $2.81B | $2.88B | $72.24M | 2.51% |
| FQ4 2024 (Dec 2024) | $2.79B | $3.05B | $261.82M | 8.58% |
| FQ3 2024 (Sep 2024) | $2.71B | $2.91B | $199.07M | 6.85% |
| FQ1 2021 (Mar 2021) | $0B | $1.51B | $1514.45M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $1.65B | $1645.98M | 100% |
| FQ3 2021 (Sep 2021) | $0B | $1.74B | $1736.16M | 100% |